Clinical Nutrition

ENTEREX® KIDZ ULTRA

  • Nutritional Powder Shake for Children
  • Contains Probiotics and Prebiotics (FOS)
  • Calcium and Vitamin D to support Strong Bones
  • DHA Omega-3 (32 mg per serving) for Brain and Eye Health
 

 

Available Options

* Sale Unit:
Qty:   $124.79  
ENTEREX® KIDZ ULTRA

Specialized Nutritional Formula for Children® Containing Probiotics, Prebiotics (FOS), and DHA

Enterex® Kidz ULTRA is a complete and nutritionally balanced shake specially formulated for children. Each serving of Enterex® Kidz ULTRA provides protein, carbohydrates, healthy fats, vitamins and minerals and may be consumed as a convenient snack or nutritional supplement.

  • DHA Omega-3 (32 mg per serving) for Brain and Eye Health 
  • Taurine and Carnitine to support Growth and Energy
  • Good Source of  Iron and Protein
  • Special Combination of Probiotics, Fiber and  FOS to help Strengthen Digestive and Immune System Health
  • Calcium and Vitamin D to support Strong Bones
  • Lactose Free and Gluten Free
  • Over 30 Essential Nutrients per Serving
  • Delicious Vanilla Flavor

USED UNDER MEDICAL SUPERVISION.

 

PRESENTATION: POWDER

Catalog Number Units per Case Size Flavor
22450 12 cans 450 g Vanilla

 

 

 

*This product cannot be sold or distributed in the State of California or the State of Vermont

 

NUTRITIONAL INFORMATION
Nutrients per serving (225 ml)


Calories (kcal) 230
Energy (kJ) 963
Total Fat (g) 11
Trans Fat (g) 0
Omega-3(DHA)(mg) 32
Cholesterol (mg) 7.5
Sodium (mg) 115
Potassium (mg) 310
Carbohydrates (g) 26
Sugar (g) 15.5
Fiber (g) 2
Protein (g) 7
Vitamin A (IU) 305
Vitamin C (IU) 24
Calcium (mg) 230
Iron (mg) 3.3
Vitamin D (IU) 120
Vitamin E (IU) 5.4
Vitamin K (mcg) 9
   
   
   
   
   

Ingredients: INGREDIENTS: Maltodextrin (Source of Dietary Fiber), Sunflower Oil (with less than 2% of Sodium Caseinate (a milk derivative), Mono & Diglycerides, Dipotassium Phosphate, Soy Lecithin, Sodium Silico Aluminate, Tocopherols added to help protect flavor), Sugar (Sucrose), Whey Protein Concentrate, Medium Chain Triglycerides, Milk Protein Concentrate, Natural and Artificial Flavors, Fructooligosacharides (a Prebiotic), Vitamins (Philloquinone, Choline Bitartrate, M-Inositol , Vitamin E Acetate, Taurine, Niacinamide, L-Carnitine, Vitamin A Palmitate, Vitamin D3, Piridoxine Hydrochloride, Thiamine Hydrochloride, Riboflavin,Cianocobalamine, Folic Acid, Biotin) Minerals (Calcium Chloride, Calcium Ascrobate, Sodium Chloride, Monopotasium Phosphate, Monsodium Phosphate, Magnesium Gluconate, , Zinc Sulfate, Calcium Pantothenate, Ferrous Sulfate, Manganese Sulfate, Copper Sulfate, Chromium Chloride, Potassium Iodide, Sodium Molibdenate, Sodium Selenite, Choline Chloride) Probiotics (L. acidophilus, B. longum, B. bifidum, and B. lactis) Carrageenan, Refined Fish Oil (Tuna) (Source of DHA), Cellulose Gum, Soy Lecithin, Caramel Color. Contains Milk and Soy Ingredients.

 

 

Caloric Density (kcal/mL) 1.0
Caloric Distribution
Protein (% kcal) 12
Carbohydrate (% kcal) 45
Fat (% kcal) 43
Total Calories/g N 205:1
Non-protein Calories/g N 180:1
Gluten free Yes
Lactose free Yes

Flavor: Vanilla

DIRECTIONS OF USE

Add 50g or 2 scoops (measuring scoop included inside the can) of Enterex® Kidz ULTRA to 185 ml of water and mix until the powder dissolves completely. Enterex® Kidz ULTRA provides 1 kcal/ml when mixed as directed. One 450 gram container yields approximately nine (9) 225 mL servings.

Serve cold.

Refrigerate unused portion and consume within 24 hours.

PRECAUTIONS

This product is not intended for children under one year of age unless specified by a healthcare professional. 

This product should not be used by children with Galactosemia. 

For oral or Enteral use only.

NOT FOR PARENTERAL USE.

 

We currently have no frequently asked questions for this product. If you have any questions please click here.

PEDIATRIC NUTRITION

  • Whitney EN, Rolfes SR. Life Cycle Nutrition: Infancy, Childhood, and Adolescence. Understanding Nutrition,7th Edition. 1996:577-609.
  • Lucas B. Nutrition in childhood. Krause’s Food, Nutrition, and Diet Therapy, 9th Edition. LK Mahan, S Escott-Stump, eds. WB Saunders Company, 1996:257-74.
  • Centers for Disease Control and Prevention. Pediatric nutrition surveillance, 1997 full report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.

OMEGA-3 FATTY ACIDS & DOCOSOHEXAENOIC ACID (DHA)

  • American Dietetic Association. Position of the American Dietetic Association and Dietitians of Canada: Fatty Acids. J Am Diet Assoc. 2007;107:1599-1611.
  • American Dietetic Association. Nutrition Fact Sheet: DHA: A Good Fat. 2008.
  • Arterburn LM, Hall EB, Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83(suppl):1467S-76.
  • Birch EE, Castañeda YS, Wheaton DH, Birch DG, Uauy RD, Hoffman DR. Visual maturation of term infants fed long-chain polyunsaturated fatty acid–supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871–9.
  • Carrero JJ, Martín-Bautista E, Barò L, Fonollá J, Jimé;nez J, Boza JJ, López-Huertas E. Efectos cardiovasculares de los ácidos grasos omega-3 y alternativas para incrementar su ingesta. Nutr Hosp. 2005;20(1): 63-9.
  • Engler MM, Engler MB, Arterburn LM, Bailey E, Chiu EY, Malloy MJ, Mietus-Snyder ML. Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid compositionin hyperlipidemic children: results from the Endothelial Assessment of Risk from Lipids in Youth (EARLY) study. Nutr Res. 2004;24:721-29.
  • Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, Morrow J, Ridker P, Rifai N, Mietus-Snyder ML. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Therap. 2004;42:672-79.
  • Hoffman DR, Theuer RC, Castañeda YS, Wheaton DH, Bosworth RG, O’Connor AR, Morale SE, Wiedemann LE, Birch EE. Maturation of Visual Acuity is accelerated in Breast-Fed Term Infants Fed Baby Food Containing DHA-Enriched Egg Yolk. J Nutr. 2004;134:2307–13.
  • Kidd PM. Omega-3 DHA and EPA for Cognition, Behavior, and Mood: Clinical Findings and Structural-Functional Synergies with Cell Membrane Phospholipids. Alt Med Rev Volume 12, Number 3 2007;12(3):207-27
  • Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to developmentg and fuction of the brain and retina. Prog Lipid Res. 2001;40:1-94.
  • Madden SM, Garrioch CF, Holub BJ.Direct diet quantification indicates low intakes of (n-3) fatty acids in children 4 to 8 years old. J Nutr. 2009;139(3):528-32.
  • McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. 2005;82:281–95.
  • Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of Action of Docosahexaenoic Acid in the Nervous System. Lipids. 2001(36):945–59.
  • Sanhueza J, Nieto S, Valenzuela A. Acido Docosohexaenoico (DHA), Desarrollo Cerebral, Memoria, y Aprendizaje: La Importancia de la Suplementación Perinatal. Rev Chil Nutr. 2004;31(2).
  • Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr. 2005;72(3):239-42.
  • Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential Fatty Acids in Visual and Brain Development. Lipids. 2001;36(9):885-95.
  • Valenzuela A, Nieto S. Ácidos grasos omega-6 y omega-3 en la nutrición perinatal: su importancia en el desarrollo del sistema nervioso y visual. Rev Chil Pediatr. 2003;74(2):149-57.

PREBIOTICS

  • Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early Dietary Intervention with a Mixture of Prebiotic Oligosaccharides Reduces the Incidence of Allergic Manifestations and Infections during the First Two Years of Life. J Nutr. 2008;138 1091–95.
  • Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J. 2006;5:8.
  • Tashiro Y, Oike H, Aramaki K, Hirayama M, Adachi T. In vitro ferementation of fructooligosaccharides in comparison with other oligo- and polysaccharides. Abstract, Wageningen, Netherlands. 1997.
  • Veerman G. Pediatric Applications of Inulin and Oligofructose. J Nutr. 2007;137:2585S–9S.

PROBIOTICS

  • Attaie R, Whalen PJ, Shahani KM, Amer MA. Inhibition of growth of S. aureus during production of acidophilus yogurt. J Food Protect. 1987;50:224-8.
  • Ayebo AD, Angelo IA, Shahani KM. Effect of ingesting lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans. Milchwissenschaft. 1980;35:730-3.
  • Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, Albano F, Passariello A, De Marco G, Manguso F, Guarino A. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ Online. 2007.
  • Gerasimov SV. Treatment of atopic dermatitis in young children: Ongoing search for effective probiotic formulation. Scientific Report. UAS Labs, 2008:1-21.
  • Gilliland SE. Acidophilus Milk Products: A Review of Potential Benefits to Consumers. J Dairy Sci . 1989;72:2483-94.
  • Jack M, Wood BJB, Berry DR. Evidence for the involvement of thiocyanate in the inhibition of Candida albicans by L. acidophilus. Microbioscience. 1990;62:37-46.
  • Liévin-Le Moal V, Sarrazin-Davila LE, Servin AL. An Experimental Study and a Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Antisecretory Activity of Lactobacillus acidophilus Strain LB Against Nonrotavirus Diarrhea. Pediatrics. 2007;120;e795-e803
  • Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009;124(2):e172-9.
  • Lin PP, Hsieh YM, Tsai CC. Antagonistic activity of Lactobacillus acidophilus RY2 isolated from healthy infancy feces on the growth and adhesion characteristics of enteroaggregative Escherichia coli. Anaerobe. 2009.
  • Moorthy G, Murali MR, Niranjali Devaraj S. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella-host interactions. Dig Liver Dis. 2009.
  • Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol. 2009;15(26):3261-8.
  • Rangavajhyala N, Shahani KM, Sridevi G, Srikumaran S. Nonlipopolysaccharide components of L. acidophilus stimulate the production in interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutr Cancer. 1997;28:130-4.
  • Shahani KM. Isolation and study of anticarcinogenic agents from lactobacillus fermented food systems. Final Report. Damon Runyan Memorial Fund for Cancer Research, Inc., 1969.
  • Shahani KM, Vakil JR, Kilara A. Natural antibiotic activity of L. acidophilus and bulgaricus. Cultural conditions for the production of antibiosis. Cult Dairy Prod J. 1976;11:14-7.
  • Shahani KM, Vakil JR, Kilara A. Natural antibiotic activity of L. acidophilus and bulgaricus. II. Isolation of acidophilin from L. acidophilus. Cult Dairy Prod J. 1977;12:8-11.
  • Tabbers MM, Chmielewska A, Roseboom MG, Boudet C, Perrin C, Szajewska H, Benninga MA. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571). BMC Pediatrics. 2009;9:22.
  • Vakil JR, Shahani KM. Partial purification of antibacterial activity of L. acidophilus. Bact Proc. 1965:9.
  • Walker DK, Gilliland SE. Relationships among bile tolerance, bile salt deconjugation and assimilation of cholesterol by L. acidophilus. J Dairy Science. 1993;76:956-61.
  • Yasmin T, Stohs SJ, Chatterjee A, Bagchi D. Inhibition of H. pylori by L. acidophilus DDS1, clarithromycin, Protykin and garcinol. Abstracts of the General Meeting of the American Society for Microbiology. 2002;102:166.
  • Zychowicz C, Kowalczyk S, Cleplinska T. Effect of L. acidophilus cultures (acidophilus milk) on the carrier state of Shigella and Salmonella organisms in children. Pediatria Polska. 1974;49:997.
  • Zychowicz C, Surazynska A, Siewierska B, Cleplinska T. Results of administration of L. acidophilus cultures (acidophilus milk) in an endemic focus of dysentery. Pediatria Polska. 1977;50:429.

TAURINE

  • Heird WC. Taurine in neonatal nutrition – revisited. Arch Dis Child Fetal Neonatal Ed. 2004;89:F473–4.
  • Wharton BA, Morley R, Isaacs EB, Cole TJ, Lucas A. Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed. 2004;89:F497–8.

CARNITINE

  • Crill C, Storm M, Christensen ML, Hankins CT, Jenkins MB, Helms RA. Carnitine supplementation in premature neonates: Effect on plasma and red blood cell total carnitine concentrations, nutrition parameters, and morbidity. Clin Nutr. 2006(25).
  • Melegh B, Kerner J, Sándor A, Vincellér M, Kispál G. Oral L-carnitine supplementation in low-birth-weight newborns: a study on neonates requiring combined parenteral and enteral nutrition. Acta Paediatr Hung. 1986;27(3):253-8.